Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03921242 · ClinicalTrials.gov registry record
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 4,888
- Enrollment target
NCT03921242: Completed study, sponsored by Weill Medical College of Cornell University.
NCT03921242 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 4,888 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03921242 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 4,888 participants
- Enrollment target
Study Summary
This is a proposal for a retrospective observational study of the safety of metformin use in patients with chronic kidney disease, compared to other commonly used diabetes drugs. It will be conducted using retrospective data from the New York City CDRN, Medicare administrate files, and New York State Medicaid administrative files, which will be linked and then deidentified prior to analysis.
Primary Outcome
Comparing the time-to event outcomes between metformin and other index exposures. Severe Hypoglycemic events are defined as events resulting in emergency room, observation, or inpatient visits where hypoglycemia is the primary diagnosis
Interventions
- DRUG Metformin
- DRUG SGLT2 inhibitor
- DRUG Sulfonylurea
- DRUG DPP-4 inhibitor
- DRUG GLP1 receptor agonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,888 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2023-08-01 |
What the finished NCT03921242 record still lists
NCT03921242 is an observational study that tracks outcomes without assigning an intervention. Its 4,888 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which Metformin is the first listed.
NCT03921242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03921242 about?
NCT03921242 is a clinical study titled "Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease". This is a proposal for a retrospective observational study of the safety of metformin use in patients with chronic kidney disease, compared to other commonly used diabetes drugs. It will be conducted using retrospective data from the New York City CDRN, Medicare administrate files, and New York Stat...
What is the current status of trial NCT03921242?
This trial is currently completed. The enrollment target is 4,888 participants. The study started on 2019-08-01. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT03921242?
The interventions under investigation include: Metformin (DRUG), SGLT2 inhibitor (DRUG), Sulfonylurea (DRUG), DPP-4 inhibitor (DRUG), GLP1 receptor agonist (DRUG).
Who is sponsoring clinical trial NCT03921242?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI